Agilent, GKPC-105, AdvanceBio InstantPC Man7 / M7 N-glycan standard

AdvanceBio InstantPC Man7 / M7 N-glycan standard. N-glycan (oligomannose 7) labeled with InstantPC, for use as a qualitative standard in applications such as liquid chromatography (LC) and mass spectrometry (MS).

Specifications:
Chemical Structure:
Label: InstantPC
Monoisotopic Mass: MWGlycan + 261.14773 = 1819.6867
Name: Man7
Oxford Name: M7
Standard Type: High Mannose-type Native N-Glycan
Unit: 25 Injections

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Agilent's AdvanceBio InstantPC Man7 M7 N-glycan standard provides a high-quality, ready-to-use reference standard for quantitative and qualitative analysis of N-linked glycans. This highly purified standard supports confident identification and accurate retention time alignment during glycan profiling workflows. Labeled with the InstantPC dye, it ensures enhanced sensitivity and reliable fluorescence detection, making it ideal for HILIC UHPLC and LC-MS applications. The product is designed to facilitate method development, system suitability testing, and instrument calibration in biopharmaceutical research, particularly for monoclonal antibody and glycoprotein characterization. Use this standard to validate glycan structure assignments, monitor analytical performance, and streamline comparison across different batches or laboratories. AdvanceBio InstantPC-labeled glycan standards are fully compatible with Agilent InfinityLab LC systems, AdvanceBio Glycan Mapping columns, and OpenLab software, as well as other major HPLC, UHPLC, and MS platforms. Integrate this standard into routine quality control, lot release, and biosimilar comparability studies to achieve consistent and reproducible results. For a complete workflow, combine with Agilent’s glycan sample preparation kits, columns, and software solutions designed to address the challenges of glycan analysis in life science and biopharma environments.